Trial Site Detail

 

Drug:
Imatinib
Trial:
Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Terminated

 

Washington Cancer Institute

110 Irving St     
Washington , DC 20010
USA

 

Principal Investigator:
 Dennis A. Priebat, MD
Contact:
 Jason Yaffe 202-877-8618 jason.c.yaffe@medstar.net
Activation Status of this Site:
 Closed
Notes about this Site:
Washington Cancer Institute Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.